TD Cowen Maintains Buy on Edwards Lifesciences, Raises Price Target to $121
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice TargetHot
TD Cowen analyst Joshua Jennings maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $117 to $121.
TD Cowen analyst Joshua Jennings maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $117 to $121.